Area of research
Hematology · Rheumatology
Research interest
Research interests include Medicine, Immunology, Internal medicine, Systemic lupus erythematosus, Interferon, and Biology.
Gain-of-function human <i>UNC93B1</i> variants cause systemic lupus erythematosus and chilblain lupus
Functional diversity of <i>NLRP3</i> gain-of-function mutants associated with CAPS autoinflammation
Mendelian Causes of Autoimmunity: the Lupus Phenotype
Interleukin (IL)-1/IL-6-Inhibitor–Associated Drug Reaction With Eosinophilia and Systemic Symptoms (DReSS) in Systemic Inflammatory Illnesses
DOCK11 deficiency in patients with X-linked actinopathy and autoimmunity
Hyper inflammatory syndrome following COVID-19 mRNA vaccine in children: A national post-authorization pharmacovigilance study
Human OTULIN haploinsufficiency impairs cell-intrinsic immunity to staphylococcal α-toxin
COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study
Enhanced cGAS-STING–dependent interferon signaling associated with mutations in ATAD3A
Prior infection by seasonal coronaviruses, as assessed by serology, does not prevent SARS-CoV-2 infection and disease in children, France, April to June 2020
Inflammatory myopathies in childhood
SARS-CoV-2-related paediatric inflammatory multisystem syndrome, an epidemiological study, France, 1 March to 17 May 2020
Overview of STING-Associated Vasculopathy with Onset in Infancy (SAVI) Among 21 Patients
Contribution of rare and predicted pathogenic gene variants to childhood-onset lupus: a large, genetic panel analysis of British and French cohorts
Effectiveness and safety of ruxolitinib for the treatment of refractory systemic idiopathic juvenile arthritis like associated with interstitial lung disease : a case report
Monogenic lupus: Dissecting heterogeneity
Anti-MDA5 juvenile idiopathic inflammatory myopathy: a specific subgroup defined by differentially enhanced interferon-α signalling
Detection of interferon alpha protein reveals differential levels and cellular sources in disease
Blau Syndrome–Associated Uveitis: Preliminary Results From an International Prospective Interventional Case Series
Myogenic Progenitor Cells Exhibit Type I Interferon–Driven Proangiogenic Properties and Molecular Signature During Juvenile Dermatomyositis
International and multidisciplinary expert recommendations for the use of biologics in systemic lupus erythematosus
Efficacy of the Janus kinase 1/2 inhibitor ruxolitinib in the treatment of vasculopathy associated with TMEM173-activating mutations in 3 children
Assessment of Type I Interferon Signaling in Pediatric Inflammatory Disease
Spondyloenchondrodysplasia Due to Mutations in ACP5: A Comprehensive Survey
Challenges of Diagnosing Cognitive Dysfunction With Neuropsychiatric Systemic Lupus Erythematosus in Childhood
Cytokines in systemic juvenile idiopathic arthritis and haemophagocytic lymphohistiocytosis: tipping the balance between interleukin-18 and interferon-γ
Biological treatment in systemic juvenile idiopathic arthritis: achievement of inactive disease or clinical remission on a first, second or third biological agent
Gain-of-function mutations in IFIH1 cause a spectrum of human disease phenotypes associated with upregulated type I interferon signaling
Phenotypic and genotypic characteristics of cryopyrin-associated periodic syndrome: a series of 136 patients from the Eurofever Registry
Blau syndrome: cross-sectional data from a multicentre study of clinical, radiological and functional outcomes